Ancora Advisors, LLC

SEC CIK: 0001446114
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SPRY holding history

ARS Pharmaceuticals, Inc. in every 13F filed by Ancora Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRY overview All 13F holders of SPRY Full Q2 2026 holdings

Shares (Q1 2025): 0; Sold out in Q1 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2024

Holdings of SPRY by Ancora Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2025	0	$0	0.0%	−6,000−100.0%	Sold out	Holders
Q4 2024	6,000	$63.3K	<0.1%	−29,000−82.9%	Reduced	Holders
Q3 2024	35,000	$507.5K	<0.1%	+35,000	New	Holders